Compounds > cyproterone acetate, ethinyl estradiol drug combination
Page last updated: 2024-08-26

cyproterone acetate, ethinyl estradiol drug combination and Adrenal Hyperplasia, Congenital

cyproterone acetate, ethinyl estradiol drug combination has been researched along with Adrenal Hyperplasia, Congenital in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Herer, P; Luboshitzky, R; Shen-Orr, Z1
Hammerstein, J1

Other Studies

2 other study(ies) available for cyproterone acetate, ethinyl estradiol drug combination and Adrenal Hyperplasia, Congenital

ArticleYear
Urinary 6-sulfatoxymelatonin excretion in hyperandrogenic women: the effect of cyproterone acetate-ethinyl estradiol treatment.
    Experimental and clinical endocrinology & diabetes : official journal, German Society of Endocrinology [and] German Diabetes Association, 2004, Volume: 112, Issue:2

    Topics: Adrenal Hyperplasia, Congenital; Adult; Androgen Antagonists; Case-Control Studies; Cyproterone Acetate; Drug Combinations; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Hirsutism; Humans; Hyperandrogenism; Melatonin; Polycystic Ovary Syndrome

2004
[Current status of gynecologic hormone therapy. Hyperandrogen disorders].
    Archives of gynecology, 1985, Volume: 238, Issue:1-4

    Topics: Adrenal Hyperplasia, Congenital; Androgen Antagonists; Androgens; Cyproterone; Cyproterone Acetate; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Infertility, Female; Testosterone

1985